Biotalys NV (EBR:BTLS)

Belgium flag Belgium · Delayed Price · Currency is EUR
2.530
-0.070 (-2.69%)
Mar 2, 2026, 11:25 AM CET
Market Cap97.55M -18.1%
Revenue (ttm)n/a
Net Income-14.83M
EPS-0.42
Shares Out37.52M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume16,503
Average Volume43,105
Open2.520
Previous Close2.600
Day's Range2.500 - 2.550
52-Week Range2.480 - 5.500
Beta0.86
RSI28.62
Earnings DateMar 27, 2026

About Biotalys NV

Biotalys NV, an agricultural technology company, discovers and develops protein-based biocontrol solutions in Belgium and internationally. The company offers biofungicides and bioinsecticides. It also provides the AGROBODY Foundry technology platform, which generates protein-based crop protection products. In addition, the company develops EVOCA 1st generation, EVOCA Next generation, and BIOFUN-6 targeting botrytis, powdery mildew, and anthracnose in fruits and vegetables; BIOFUN-7 targeting leafspot disease in cowpeas and other legumes; BIOFUN... [Read more]

Sector Materials
Founded 2013
Employees 63
Stock Exchange Euronext Brussels
Ticker Symbol BTLS
Full Company Profile

Financial Performance

Financial Statements

News

Biotalys Secures EPA Approval For EVOCA, First Protein-Based Biofungicide

(RTTNews) - Biotalys (BTLS.BR) announced that the U.S. Environmental Protection Agency (EPA) has granted regulatory approval for its breakthrough biofungicide, EVOCA. Developed using the company's pro...

3 months ago - Nasdaq